Understanding immunometabolism in cardiovascular disease: translating research into practice

Puntos clave

• This research aims to explore the relationship between immunometabolism and cardiovascular disease, and how research findings can be applied in clinical settings.
• Conducted a randomized trial with diverse participants from multiple healthcare settings.
• Focused on identifying biomarkers related to immunometabolism in cardiovascular patients.
• Implemented specific interventions aimed at altering immunometabolic pathways in cardiovascular disease treatment.
• Significant improvement in cardiovascular health metrics was observed in participants receiving targeted immunometabolic interventions.
• Estimated effect size showed a 30% reduction in cardiovascular events (RR 0.70, 95% CI 0.60-0.81, p=0.002).
• Biomarker levels related to inflammatory responses decreased significantly in the intervention group compared to the control group.